Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.

@article{Rex2005SingleinstitutionEI,
  title={Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.},
  author={Jordi Rex and Cristina Paradelo and Cristina Mangas and Josep Maria Hilari and Maria Teresa Fernandez-Figueras and Manuel Fraile and Antoni Alastru{\'e} and Carlos Ferr{\'a}ndiz},
  journal={Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]},
  year={2005},
  volume={31 11 Pt 1},
  pages={1385-93}
}
BACKGROUND Lymphatic mapping and sentinel lymph node biopsy (SLNB) has been developed as a minimally invasive technique to determine the pathologic status of regional lymph nodes in patients without clinically palpable disease and incorporated in the latest version of the American Joint Committee on Cancer (AJCC) staging system for cutaneous melanoma. OBJECTIVE To analyze the results of SLNB and the prognostic value of the micrometastases and the pattern of early recurrences in patients… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

Similar Papers

Loading similar papers…